Store

Home | Store | Target Enrichment and Library Preparation for Next-Generation Sequencing, 2026
brand-logo

Target Enrichment and Library Preparation for Next-Generation Sequencing, 2026

Publication Date: July 7, 2026

SKU: 26-041KA

Tags: Biotechnology, Life Science, Life Science Instrumentation, Life Sciences, Next-Generation Sequencing (NGS)

Pages: 136

SKU: 26-041KA

Kalorama Information’s Target Enrichment and Library Preparation for Next-Generation Sequencing, 2026 delivers a comprehensive, forward-looking evaluation of one of the most technically dynamic and commercially consequential segments of the life science tools industry. As next-generation sequencing continues its rapid expansion across research, clinical diagnostics, biopharma drug discovery, and applied markets, the upstream sample preparation workflow—encompassing DNA and RNA library preparation, target enrichment, fragmentation, size selection, and quality control—has become a critical enabler of downstream sequencing performance, data quality, and overall cost efficiency.

This report reflects a market in active transition. With sustained growth in clinical adoption of NGS-based assays, the library preparation and target enrichment segment is navigating a new phase defined by intensifying sequencer competition, continued price pressure, rapid technology diversification, and the emergence of multi-omic workflows that are fundamentally reshaping how samples are prepared.

The report examines how these converging forces—combined with the accelerating shift to clinical applications, the maturation of long-read sequencing, and the growing influence of artificial intelligence—are reshaping product strategies, competitive positioning, and market growth trajectories through 2030.

Market Overview and Growth Drivers

The global market for NGS library preparation and target enrichment products is analyzed across major geographies, including North America, Europe, Asia Pacific, and the rest of the world, with discussion of regional demand patterns and market shares. Growth is being driven by a confluence of structural tailwinds: the continued expansion of the installed base of next-generation sequencers across thousands of research and clinical laboratories worldwide; the rapid adoption of NGS in precision oncology, rare disease diagnostics, and non-invasive prenatal testing; expanding population-scale genomics initiatives; and the ongoing transition of sequencing into decentralized and clinical settings that demand higher sample throughput and faster, more automated workflows.

At the same time, growth will face headwinds from ongoing price compression across the sequencing workflow, as competition intensifies at both the instrument and consumables levels. The falling cost of sequencing itself is increasing scrutiny of upstream preparation costs, and labs are increasingly evaluating kit switching, workflow consolidation, and ultra-high-multiplexing strategies to lower per-sample expenditures. Vendors are responding with innovations ranging from PCR-free and room-temperature-stable kits to extreme-multiplexing indexing strategies that allow thousands of samples to be prepared in a single run.

Key Trends Shaping the Market

This edition provides in-depth analysis of the defining trends reshaping library preparation and target enrichment, including:

  • Automation and workflow simplification
  • Convergence of multi-omic workflows
  • Maturation and mainstreaming of epigenetics
  • Long-read sequencing driving new preparation requirements
  • Accelerating clinical adoption
  • Sequencer market disruption and platform diversification
  • AI-driven product design and data interpretation
  • Cold-chain independence and sustainability

Competitive Landscape

The library preparation and target enrichment market is led by Illumina, with Agilent Technologies, Twist Bioscience, IDT/Danaher, Thermo Fisher Scientific, Roche/KAPA, and Qiagen among the other major suppliers. A substantial portion of the market is distributed among a large and growing number of specialized suppliers, including NEB, Oxford Nanopore, PacBio, Revvity/NEXTFLEX, Takara Bio, Watchmaker Genomics, MGI/BGI, and numerous emerging vendors. Detailed market share estimates by company are provided within the report.

Twist Bioscience has emerged as one of the fastest-growing consumables suppliers, driven by its silicon-based DNA synthesis platform and hybridization-capture panels that are now embedded in Illumina’s own branded exome enrichment products. IDT has built one of the broadest platform-agnostic portfolios through its xGen product line, with compatibility across multiple sequencing platforms and an increasingly comprehensive assay portfolio following the Archer acquisition. Agilent’s SureSelect franchise remains a major force in target enrichment, while NEB occupies a distinctive position as both an OEM supplier to Illumina and an independent library preparation innovator. The report profiles thirteen major companies in depth, including 10X Genomics, Agilent, Illumina, IDT, NEB, Oxford Nanopore, PacBio, Qiagen, Revvity, Roche, Takara Bio, Thermo Fisher, and Twist Bioscience.

Scope and Methodology

The report provides global coverage of the NGS library preparation and target enrichment market, with analysis spanning North America, Europe, Asia Pacific, and rest-of-world regions, along with discussion of regional demand patterns and market shares. It evaluates the impact of regulatory frameworks—including FDA IVD clearances and companion diagnostic approvals, CMS reimbursement decisions, LDT-related oversight, and international approval processes under the EU IVDR—as well as reimbursement trends and evidence requirements shaping clinical adoption.

Market estimates are presented at the manufacturer level, with 2025 as the base year and forecasts through 2030. The analysis incorporates primary and secondary research, internal databases, SEC filings, product literature, corporate websites, conference presentations, scientific journals, and trade publications. The report assesses growth drivers such as sequencer platform expansion, the evolution of clinical NGS, adoption of long-read technologies, multi-omic workflow development, and the competitive dynamics reshaping the consumables landscape.

Report Coverage

The report is organized across seven chapters:

  • Executive Summary — market overview, key growth drivers, and structural trends
  • Trends — detailed analysis of technology, workflow, regulatory, and competitive trends shaping the market
  • Products — comprehensive listing of current library preparation, target enrichment, and sample preparation products and technologies, including recent product introductions
  • Revenues — market sizing, multi-year forecasts, regional breakouts, and analysis of leading supplier consumables revenues
  • Competitive Analysis — market share estimates, competitive positioning, and an assessment of leading and emerging suppliers
  • Deals — selected significant collaborations, licensing agreements, and acquisitions in the NGS library preparation and target enrichment market
  • Corporate Profiles — in-depth profiles of major market participants covering strategy, product portfolios, revenues, and key partnerships

Chapter 1: Executive Summary

About Kalorama Information

Introduction

Product Introductions, Indications of Price Pressure

Stability Yielding to Diversity and Potential Disruption

A Period of Rapid Adoption, But Lower Prices

High Likelihood of Longer-Term Challenges

Size and Growth of the Market

Scope and Methodology

Applications and Definitions

Chapter 2: Market and Technology Trends

Falling Costs, Improved Output, Smaller and Simpler

Broad Range of Deals and Acquisitions

Challenges to Illumina’s Position Lead to Changes

Integration of Multi-Omic Techniques

New Epigenetics Techniques Bring Advantages

Importance of Speed, Automation, and Low-Input Samples

Long-Read Technologies Maturing

Accelerating Impact of AI

Decreasing Prices Continue Shaping the Market

Cold Chain and Sustainability Product Features

Products Across Multiple Platforms

China Becoming a Major Market Player

Acceptance and Validation of Clinical Applications

Settlement or Resolution of Litigation

Success in Microbiology and Pathogen Detection

Regulatory Trends and Announcements

  • Table 2-1: Regulatory, Reimbursement, and Other Announcements in the NGS Library Preparation and Target Enrichment Market, June 2021–April 2026

Chapter 3: Products and Technologies

  • Table 3-1: Selected Library Preparation and Target Enrichment Products and Technologies, May 2026

Product Launches

2026 Products

2025 Products

2024 Products

2023 Products

2022 Products

2021 Products

Chapter 4: Market Size and Revenue Analysis

Revenues Forecast

  • Figure 4-1: Estimated Cost of Sequencing a Human Genome, 1990–2026 (US$)

Revenue 2025-2030

  • Table 4-1: NGS Library Preparation and Target Enrichment Market Revenues, 2025–2030 (US$ Millions)
  • Figure 4-2: NGS Library Preparation and Target Enrichment Market Revenues, 2025–2030 (US$ Millions)
  • Table 4-2: NGS Library Preparation and Target Enrichment Market Growth Rate, 2025–2030 (%)
  • Figure 4-3: NGS Library Preparation and Target Enrichment Market Growth Rate, 2026–2030 (%)

Revenues by Region

  • Table 4-3: Estimated NGS Sample Preparation Revenues, by Region, 2025 (US$ Millions, %)
  • Figure 4-4: Estimated NGS Sample Preparation Revenues, by Region, 2025 (US$ Millions)
  • Figure 4-5: NGS Sample Preparation Regional Market Share, 2025 (%)

Illumina Sequencing Consumables Revenues

  • Table 4-4: Illumina Quarterly Sequencing Consumables Revenues, Q1 2014–Q1 2026 (US$ Millions)
  • Figure 4-6: Illumina Quarterly Sequencing Consumables Revenues, Q1 2014–Q1 2026 (US$ Millions)
  • Table 4-5: Contribution of Consumables to Illumina Revenue, 2016–2025 (US$ Millions, %)
  • Figure 4-7: Contribution of Consumables to Illumina Revenue, 2016–2025 (US$ Millions, %)
  • Table 4-6: Illumina Sequencing Consumables Growth Rates, 2016-2025 (%)
  • Figure 4-8: Illumina Sequencing Consumables Growth Rates, 2016-2025 (%)

Chapter 5: Competitive Landscape and Market Shares

Introduction

Continued Growth and Technological Advances

Sequencer Competition Returning

Library Preparation and Target Enrichment Market

  • Table 5-1: Estimated Library Preparation and Target Enrichment Market Revenue and Shares,  by Company, 2025  (US$ Millions, %)
  • Figure 5-1: Estimated Library Preparation and Target Enrichment Revenues, by Company, 2025 (US$ Millions)
  • Figure 5-2: Estimated Library Preparation and Target Enrichment Shares, by Company, 2025 (%)

Smaller Companies Experiencing Mixed Success

Chapter 6: Market Deals

  • Table 6-1: Selected Significant Deals in the NGS Library Preparation and Target Enrichment Market, Recent Years

Chapter 7: Corporate Profiles

10x Genomics

Agilent Technologies

Illumina

Integrated DNA Technologies (Danaher)

New England Biolabs

Oxford Nanopore

Pacific Biosciences

Qiagen

Revvity

Roche

Takara Bio

Thermo Fisher Scientific

Twist Bioscience

Our Knowledge Center provides access to

all market reports